English

Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

询价与订购

  • Name*

  • Phone*

  • Email*

  • Product*

  • Content*

Anti-PCSK9重组抗体|科研级 Bococizumab ( 伯考赛珠单抗 )

CatNo:TKYR1327

  • 1mg
  • 5mg
WeChat QR
Contact Us
instructions
MSDS
WeChat QR
Contact Us
  • Detailed
  • Background
  • Plan&FAQ
  • Related
  • Recommended
  • Detailed related information

    Catalog Number

    TKYR1327

    Alias

    科研级 Bococizumab ( 伯考赛珠单抗 ), Anti-PCSK9 Recombinant Antibody, Research Grade Bococizumab

    Molecular Name

    Bococizumab

    Size

    1mg, 5mg

    CAS Number

    1407495-02-6

    Isotype

    IgG2 Kappa

    Clonality

    Monoclonal

    Concentration

    1mg/ml

    Applications

    FC, IP, ELISA, Neut, FuncS

    Source

    CHO Cells

    Purity

    ≥95% as determined by SDS-PAGE

    Buffer

    Supplied in PBS, PH7.5

    Target

    PCSK9/NARC1/ PC9[Homo sapiens]

    Sequence

    Please contact our sales representative to learn more information about this reagents.

    Background

    Bococizumab (USAN, development code RN316) is a drug that was in development by Pfizer targeting PCSK9 to reduce LDL cholesterol. Pfizer withdrew the drug from development in November 2016, determining that it was "not likely to provide value to patients, physicians or shareholders."

    Storage

    该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。

    NOTE

    仅科研使用
    Target background information
    Experimental Plan&FAQ

    To experience the reliable service of Tekbiotech please subscribe: